Konstantin Poukalov Lian Bio (LIAN) insider trading activity

Konstantin Poukalov is Director of LianBio. Currently has a direct ownership of 17,082 shares of LIAN, which is worth approximately $5,124. The most recent transaction as insider was on Feb 15, 2024, when has been sold 19,218 shares (Ordinary Shares) at a price of $4.76 per share, resulting in proceeds of $91,477. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.1K

0% 3M change

n/a 12M change

Total Value Held $5,124

Konstantin Poukalov Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Feb 15 2024	SELL Payment of exercise price or tax liability	$91,477 $4.76 p/Share	19,218 Reduced 52.94%	17,082 Ordinary Shares
Feb 15 2024	BUY Exercise of conversion of derivative security	$91,476 $2.52 p/Share	36,300 Added 50.0%	36,300 Ordinary Shares

Also insider at

LABP

Landos Biopharma, Inc. Healthcare

Director

LYRA

Lyra Therapeutics, Inc. Healthcare

ARYD

ARYA Sciences Acquisition Corp IV Financial Services

Chief Business Officer